Variance in albumin loading in exchange transfusions.

Area of Science:

• Neonatal Medicine
• Pediatric Hematology
• Clinical Biochemistry

Background:

• Hyperbilirubinemia is a common condition in newborns.
• Exchange transfusion is a treatment for severe hyperbilirubinemia.
• Albumin is sometimes used to enhance bilirubin binding before exchange transfusion.

Purpose of the Study:

• To evaluate the effectiveness of albumin priming before exchange transfusion in hyperbilirubinemic infants.
• To determine if albumin administration improves bilirubin removal during exchange transfusion.

Main Methods:

• 42 hyperbilirubinemic infants requiring exchange transfusion were randomized into two groups.
• Group I received 1 gm/kg of salt-poor human serum albumin intravenously one hour before exchange transfusion.
• Group II received simple exchange transfusion without albumin priming.

Main Results:

• No significant differences were found in reserve albumin-binding capacity (RABC), bilirubin, albumin, or red cell bilirubin levels between groups pre- and post-infusion.
• The amount of bilirubin removed per kilogram was directly correlated with plasma bilirubin concentration (r=0.87).
• Albumin priming did not significantly alter the efficiency of bilirubin removal between the two groups.

Conclusions:

• Albumin priming prior to exchange transfusion does not enhance overall bilirubin removal efficiency in hyperbilirubinemic infants.
• The study suggests potential benefits of albumin therapy only in infants with pre-existing low RABC, identified via Sephadex gel filtration.
• Further research may be needed to clarify the specific role of albumin in managing neonatal hyperbilirubinemia.